Day One BiopharmaceuticalsDAWN
那斯達克 · USD
21.20
+8.42
(+65.88%)
收盤 03/07 04:59 (UTC+8)
盤後
21.23
+0.03
(+0.14%)
03/07 04:59 (UTC+8)
Day One BiopharmaceuticalsDAWN
21.20
+8.42
(+65.88%)
財務數據
損益表
- -
- -
- -
- 0.08
- 0.94
- 0.29
- 0.31
- 0.34
- 0.40
- 0.54
- -
- -
- -
- -
- 1044.54
- -68.85
- 5.32
- 10.23
- 17.36
- 34.99
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 53,718 | 39,795 | 33,908 | 30,761 | 29,208 | 93,761 | 8,192 | - | - | - |
營業成本 | 6,081 | 4,480 | 3,765 | 2,884 | 2,982 | 1,590 | 707 | - | - | - |
營業毛利 | 47,637 | 35,315 | 30,143 | 27,877 | 26,226 | 92,171 | 7,485 | - | - | - |
營業費用 | 75,095 | 59,566 | 65,117 | - | - | - | - | - | - | 51,438 |
研發費用 | 40,948 | 31,419 | 36,149 | 39,619 | 61,823 | 33,563 | 92,106 | 40,210 | 37,348 | 33,163 |
推銷及管理費用 | 34,147 | 28,147 | 28,968 | 29,325 | 29,735 | 28,972 | 30,186 | 26,557 | 22,169 | 18,275 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -27,458 | -24,251 | -34,974 | -41,067 | -65,332 | 29,636 | -114,807 | -66,767 | -59,517 | -51,438 |
其他收入及費用 | 4,204 | 4,525 | 4,652 | 5,071 | 6,092 | 6,519 | 111,952 | 4,355 | 5,006 | 5,288 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -23,254 | -19,726 | -30,322 | -35,996 | -59,240 | 36,155 | -2,855 | -62,412 | -54,511 | -46,150 |
所得稅 | -1,976 | - | - | - | 6,474 | -882 | 1,552 | - | - | - |
稅後純益 | -21,278 | -19,726 | -30,322 | -35,996 | -65,714 | 37,037 | -4,407 | -62,412 | -54,511 | -46,150 |
基本每股稅後盈餘(元) | -0.21 | -0.19 | -0.29 | -0.35 | -0.63 | 0.38 | -0.05 | -0.72 | - | -0.54 |
稀釋每股稅後盈餘(元) | -0.21 | -0.19 | -0.29 | -0.35 | -0.69 | 0.44 | -0.05 | -0.72 | -0.64 | -0.53 |
基本平均股數(千股) | 103662.00 | 103381.00 | 103069.00 | 102710.00 | 102513.00 | 96623.00 | 87121.00 | 86679.00 | - | 85952.00 |
稀釋平均股數(千股) | 103662.00 | 103381.00 | 103069.00 | 102710.00 | 102199.00 | 96937.00 | 87121.00 | 86679.00 | - | 85952.00 |
還原基本每股稅後盈餘(元) | -0.21 | -0.19 | -0.29 | -0.35 | -0.63 | 0.38 | -0.05 | -0.72 | - | -0.54 |
還原稀釋每股稅後盈餘(元) | -0.21 | -0.19 | -0.29 | -0.35 | -0.69 | 0.44 | -0.05 | -0.72 | -0.64 | -0.53 |
還原基本平均股數(千股) | 103,662 | 103,381 | 103,069 | 102,710 | 102,513 | 96,623 | 87,121 | 86,679 | - | 85,952 |
還原稀釋平均股數(千股) | 103,662 | 103,381 | 103,069 | 102,710 | 102,199 | 96,937 | 87,121 | 86,679 | - | 85,952 |
EBITDA(千元) | -25,475 | -22,913 | -33,510 | -39,352 | -61,304 | 35,524 | -3,344 | -63,588 | -55,984 | -48,695 |